NCT04062396View on ClinicalTrials.gov

Comparison of Remowell 2 and Inspire on Delirium and Cognitive Dysfunction

NACompletedINTERVENTIONAL

Enrollment

154

Participants

Timeline

Start Date

September 26, 2019

Primary Completion Date

January 23, 2023

Study Completion Date

January 23, 2023

Conditions

Cardiac SurgeryCardiopulmonary Bypass

Interventions

DEVICE

Eurosets REMOWELL 2 oxygenator

The main characteristic of REMOWELL 2 oxygenator is the presence of a filtration system for extracavitary inlet. Multilayer cascade filtration and supernatant separator leads to lipid-leukocytes depletion

DEVICE

LivaNova INSPIRE oxygenator

INSPIRE oxygenator has no filtration system for extracavitary inlet

Trial Locations (1)

48010

Maria Cecilia Hospital, Cotignola

All Listed Sponsors

lead

Maria Cecilia Hospital

OTHER

NCT04062396 - Comparison of Remowell 2 and Inspire on Delirium and Cognitive Dysfunction | Biotech Hunter | Biotech Hunter